T1	eligibility 772 886	Postmenopausal women with hormone-sensitive early breast cancer who had completed 2 years' adjuvant oral tamoxifen
T2	intervention 944 955	anastrozole
T3	intervention-participants 959 963	1618
T4	control 980 989	tamoxifen
T5	control-participants 993 997	1606
T6	outcome-Measure 1075 1094	event-free survival
T7	total-participants 1218 1222	3224
T9	outcome 1326 1343	risk for an event
T10	iv-bin-abs 1407 1409	67
T11	cv-bin-abs 1437 1440	110
T14	outcome 1578 1587	fractures
T15	outcome 1622 1632	thromboses
T8	outcome 1532 1546	well tolerated
